Contract research news in brief
pharmafile | March 22, 2013 | News story | Research and Development |Â Â Calvert labs, Frontage Labs, Medrio, Mytrus, Particle Sciences, Sotio, chiltern, inVentiv HealthÂ
inVentiv takes stake in Mytrus, Frontage Labs FDA-inspected, plus updates from Chiltern, Calvert Labs/Particle Sciences and Medrio.
US contract research organisation (CRO) inVentiv Health has taken an equity stake in Mytrus, which specialises in virtual clinical trials and related technologies such as electronic informed consent that can be used to allow studies to be carried out in patients’ own homes, reducing study costs and boosting patient recruitment. “Our partnership with Mytrus will allow us to recruit and retain a broader base of patients more quickly,” said inVentiv’s president Ray Hill.
Chinese CRO Frontage Laboratories has completed FDA inspections of its clinical research centre in Zhengzhou and bioanalytical lab in Shanghai, with one Form 483 issued for the Shanghai unit that is currently being resolved, according to the company’s chief executive Song Li. Frontage is the first company in China to offer combined clinical trial and bioresearch monitoring programmes from FDA-inspected facilities, he added.
Czech Republic-based biopharma company Sotio has awarded Chiltern International as the European CRO for its Phase III trial of a dendritic cell-based immunotherapy for prostate cancer. Chiltern will provide full-service management of the EU arm of the 1,170-patient VIABLE trial, which will take place across 126 treatment centres.
Calvert Laboratories has formed an alliance with Particle Sciences in the area of preclinical drug development. The two companies will work together on preclinical toxicology and formulation development to help customers bring their drug candidates forward to the clinic more quickly. “Formulation is often one of the most significant challenges our clients’ face,” commented Calvert’s chief scientific officer Charles Spainhour.
eClinical company Medrio is making its electronic data capture (EDC) software available free of charge to organisations running trials that are university and/or government funded. The platform – which can be signed up for here – is fully validated and meets regulatory requirement in the US and Europe. It can be used to collect and manage data for clinical trials, registries, retrospective studies and patient web surveys, said the company.
Phil Taylor
Related Content
INC Research and inVentiv merge to form Syneos Health
With the advent of the new year, INC Research and inVentiv Health have announced they …
NHS approves electronic consent technology in clinical trials
Clinical technology and services company Mytrus has announced that its software platform for electronic informed …
Chiltern acquires Ockham to help lift status
Chiltern has today acquired a full stake in fellow contract research organisation Ockham as both …
